Ursodeoxycholic acid stimulates the formation of the bile canalicular network

Biochemical Pharmacology

Volumn 84, Issue 7, 2012, Pages 925-935

  Ikebuchi, Yuki ^a   Shimizu, Hidetoshi ^a   Ito, Kousei ^a   Yoshikado, Takashi ^a   Yamanashi, Yoshihide ^a   Takada, Tappei ^a   Suzuki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Bile acid; Bile canalicular; Biliary excretion; Ursodeoxycholic acid

Indexed keywords

DIMETHYLNITROSAMINE; GLYCOCHOLIC ACID; LIVER ENZYME; LIVER PROTECTIVE AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; TAUROCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; FUNCTIONAL MORPHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRAHEPATIC BILE DUCT; LIVER CELL; LIVER CELL CULTURE; LIVER INJURY; LIVER PROTECTION; LIVER REGENERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BILIARY TRACT; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; HEPATOCYTES; MALE; MAP KINASE KINASE KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; RATS; RATS, WISTAR; TAUROCHOLIC ACID; URSODEOXYCHOLIC ACID;

EID: 84865474602     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.07.008     Document Type: Article

References (34)

1. A.F. Hofmann The continuing importance of bile acids in liver and intestinal disease Arch Intern Med 159 1999 2647 2658
2. R.P. Oude Elferink, C.C. Paulusma, and A.K. Groen Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases Gastroenterology 130 2006 908 925 (Pubitemid 43374538)
3. K.D. Lindor, K.V. Kowdley, V.A. Luketic, M.E. Harrison, T. McCashland, and A.S. Befeler High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis Hepatology 50 2009 808 814
4. G. Paumgartner, and U. Beuers Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited Hepatology 36 2002 525 531 (Pubitemid 34977162)
5. U. Beuers Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis Nat Clin Pract Gastroenterol Hepatol 3 2006 318 328 (Pubitemid 43842248)
6. + exchange inhibitors Am J Physiol 254 1988 G232 G241
7. P. Invernizzi, A.L. Salzman, C. Szabo, I. Ueta, M. O'Connor, and K.D. Setchell Ursodeoxycholate inhibits induction of NOS in human intestinal epithelial cells and in vivo Am J Physiol 273 1997 G131 G138
8. M. Yoshikawa, T. Tsujii, K. Matsumura, J. Yamao, Y. Matsumura, and R. Kubo Immunomodulatory effects of ursodeoxycholic acid on immune responses Hepatology 16 1992 358 364
9. L. Liu, T. Sakaguchi, X. Cui, Y. Shirai, T. Nishimaki, and K. Hatakeyama Liver regeneration enhanced by orally administered ursodesoxycholic acid is mediated by immunosuppression in partially hepatectomized rats Am J Chin Med 30 2002 119 126 (Pubitemid 41758927)
10. P. Santoro, F. Raimondi, S. Annunziata, R. Paludetto, T. Annella, and F. Ciccimarra Unconjugated bile acids modulate adult and neonatal neutrophil chemotaxis induced in vitro by N-formyl-met-leu-phe-peptide Pediatr Res 51 2002 392 396 (Pubitemid 34174978)
11. M.M. Zegers, and D. Hoekstra Mechanisms and functional features of polarized membrane traffic in epithelial and hepatic cells Biochem J 336 Pt 2 1998 257 269 (Pubitemid 28564379)
12. J.W. Jonker, C.A. Stedman, C. Liddle, and M. Downes Hepatobiliary ABC transporters: physiology, regulation and implications for disease Front Biosci 14 2009 4904 4920
13. M. Strazzabosco, and L. Fabris Functional anatomy of normal bile ducts Anat Rec (Hoboken) 291 2008 653 660
14. M. Ninomiya, K. Ito, and T. Horie Functional analysis of dog multidrug resistance-associated protein 2 (Mrp2) in comparison with rat Mrp2 Drug Metab Dispos 33 2005 225 232 (Pubitemid 40216590)
15. M. Hirao, N. Sato, T. Kondo, S. Yonemura, M. Monden, and T. Sasaki Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway J Cell Biol 135 1996 37 51 (Pubitemid 26337735)
16. H. Akita, H. Suzuki, K. Ito, S. Kinoshita, N. Sato, and H. Takikawa Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump Biochim Biophys Acta 1511 2001 7 16 (Pubitemid 32206667)
17. M. Hagio, M. Matsumoto, M. Fukushima, H. Hara, and S. Ishizuka Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS J Lipid Res 50 2009 173 180
18. S. Sekine, K. Ito, and T. Horie Oxidative stress and Mrp2 internalization Free Radic Biol Med 40 2006 2166 2174 (Pubitemid 43903103)
19. K. Maeda, M. Kambara, Y. Tian, A.F. Hofmann, and Y. Sugiyama Uptake of ursodeoxycholate and its conjugates by human hepatocytes: role of Na(+)-taurocholate cotransporting polypeptide (NTCP), organic anion transporting polypeptide (OATP) 1B1 (OATP-C), and oatp1B3 (OATP8) Mol Pharmacol 3 2006 70 77 (Pubitemid 43331753)
20. E.C. Torchia, R.J. Shapiro, and L.B. Agellon Reconstitution of bile acid transport in the rat hepatoma McArdle RH-7777 cell line Hepatology 24 1996 206 211 (Pubitemid 26249435)
21. M.J. Perez, and O. Briz Bile-acid-induced cell injury and protection World J Gastroenterol 15 2009 1677 1689
22. L. McMillan, S.K. Butcher, J. Pongracz, and J.M. Lord Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases Br J Cancer 88 2003 748 753 (Pubitemid 36411455)
23. L. Qiao, A. Yacoub, E. Studer, S. Gupta, X.Y. Pei, and S. Grant Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes Hepatology 35 2002 779 789 (Pubitemid 34258371)
24. R. Wimmer, S. Hohenester, T. Pusl, G.U. Denk, C. Rust, and U. Beuers Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver Gut 57 2008 1448 1454
25. J. Wu, and P.A. Norton Animal models of liver fibrosis Scand J Gastroenterol 31 1996 1137 1143 (Pubitemid 26403086)
26. D. Fu, Y. Wakabayashi, Y. Ido, J. Lippincott-Schwartz, and I.M. Arias Regulation of bile canalicular network formation and maintenance by AMP-activated protein kinase and LKB1 J Cell Sci 123 2010 3294 3302
27. D. Fu, Y. Wakabayashi, J. Lippincott-Schwartz, and I.M. Arias Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway Proc Natl Acad Sci U S A 108 2011 1403 1408
28. A. Woods, A.J. Heslegrave, P.J. Muckett, A.P. Levene, M. Clements, and M. Mobberley LKB1 is required for hepatic bile acid transport and canalicular membrane integrity in mice Biochem J 434 2011 49 60
29. J.S. Sidhu, F. Liu, and C.J. Omiecinski Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes Exp Cell Res 292 2004 252 264 (Pubitemid 38018841)
30. G. Svegliati-Baroni, F. Ridolfi, Z. Caradonna, D. Alvaro, M. Marzioni, and S. Saccomanno Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosis J Hepatol 39 2003 528 537 (Pubitemid 37204652)
31. M. Barone, E. Maiorano, R. Ladisa, A. Pece, P. Berloco, and M. Strazzabosco Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats Virchows Arch 444 2004 554 560 (Pubitemid 38858379)
32. L.B. Chiarini, C.M. Takiya, R. Borojevic, and A.N. Monteiro Long-term culture of cholangiocytes from liver fibro-granulomatous lesions BMC Gastroenterol 6 2006 13
33. M.A. Muff, T.V. Masyuk, A.J. Stroope, B.Q. Huang, P.L. Splinter, and S.O. Lee Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease Lab Invest 86 2006 940 950 (Pubitemid 44268168)
34. S. Sekine, K. Ito, and T. Horie Canalicular Mrp2 localization is reversibly regulated by the intracellular redox status Am J Physiol Gastrointest Liver Physiol 295 2008 G1035 G1041